on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group's Latest Disclosure on Spire Healthcare
The Vanguard Group, Inc. has released a Form 8.3 disclosure concerning its interests in Spire Healthcare Group plc, detailing its involvement in relevant securities. As of June 8, 2026, Vanguard owns 14,479,362 ordinary shares, representing a 3.60% stake in Spire Healthcare.
Additionally, the disclosure reports a recent sale of 2,850 ordinary shares at a price of 2.17 GBP each. No cash-settled or stock-settled derivatives are noted in the current position.
The filing states there are no indemnity or other dealing arrangements, nor agreements concerning securities voting rights or future acquisitions. Furthermore, no Supplemental Form 8 (Open Positions) is attached to the disclosure.
The disclosure was submitted by Shawn Acker on June 9, 2026. No other parties to the Spire Healthcare offer are disclosed in this filing.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news